Author/Authors :
Masataka Ikeda، نويسنده , , Mitsugu Sekimoto، نويسنده , , Shuji Takiguchi، نويسنده , , Masayoshi Yasui، نويسنده , , Katsuki Danno، نويسنده , , Yujiro Fujie، نويسنده , , Kotaro Kitani، نويسنده , , Yosuke Seki، نويسنده , , Taishi Hata، نويسنده , , Tatsushi Shingai، نويسنده , , Ichiro Takemasa، نويسنده , , Masakazu Ikenaga، نويسنده , , Hirofumi Yamamoto، نويسنده , , Masayuki Ohue، نويسنده , , Morito Monden، نويسنده ,
Abstract :
Background
Portal or splenic vein thrombosis (PSVT) is a common disorder after laparoscopic splenectomy (LS). Splenomegaly is a well-known risk factor for PSVT. However, no treatment strategy for PSVT has been established.
Methods
Thirty-three consecutive patients who had undergone LS and postoperative imaging surveillance were examined. PSVT was classified according to the site of thrombosis. We evaluated patient background, operative factors, and clinical symptoms.
Results
Spleen weight of patients with PSVT (n = 17, median 218 g) was greater than that of patients without PSVT (n = 16, median 101 g). Seven patients developed thrombosis involving the entire splenic vein (total splenic vein thrombosis), and 4 of them had clinical symptoms (fever >38°C and/or abdominal pain). The incidence of clinical symptoms was significantly more frequent in patients with than without total SVT. Operation time, blood loss, and spleen weight were also significantly greater in patients with total SVT. Multiple logistic regression analysis demonstrated spleen weight was the strongest predictor of PSVT and total SVT.
Conclusion
Patients with total SVT have greater risk factors for PSVT and frequently have clinical symptoms. They are candidates for anticoagulation therapy.
Keywords :
Laparoscopic splenectomy , Portal or splenic vein thrombosis , Anticoagulant therapy , Total splenic vein thrombosis , Contrast-enhanced computed tomography scan